Join
Live feed
·
PRReleasevia Quantisnow
BeiGene Ltd. logo

TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

ByQuantisnow·Wall Street's wire, on your screen.
BGNE· BeiGene Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BGNE (BeiGene Ltd.) and more on Quantisnow.